Publication | Open Access
UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24 weeks of treatment
78
Citations
26
References
2017
Year
In patients with severe LC-FAOD, UX007 interim study results demonstrated improved exercise endurance and tolerance, and were associated with positive changes in self-reported HR-QoL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1